分享 收藏

Recombinant Rat IP-10/CXCL10 重組大鼠 IP-10/CXCL10

品牌：翌圣生物
產地：
供應商報價：面議

翌圣生物科技(上海)股份有限公司更新時間：2025-01-17 11:16:41

銷售范圍售全國

入駐年限第2年

營業執照已審核

同類產品趨化因子(83件)

立即掃碼咨詢

聯系方式：400-611-1883

聯系我們時請說明在儀器網（www.ghhbs.com.cn）上看到的!

掃碼分享

為您推薦

Recombinant Human Eotaxin-3/CCL266 重組人Eotaxin-3/CCL26

Recombinant Human Exodus-2/CCL21重組人 Exodus-2/CCL21
Recombinant Human I-309/CCL1重組人 I-309/CCL1

Recombinant Human LD78β/CCL3L1 重組人LD78β/CCL3L1
Recombinant Human MIP-1α/CCL3重組人MIP-1α/CCL3

Recombinant Human MCP-1/CCL2 重組人MCP-1/CCL2

詳細介紹

C–X–C motif chemokine 10 (CXCL10) also known as interferon γ-induced protein 10kDa (IP-10) or small-inducible cytokine B10 is a cytokine belonging to the CXC chemokine family. The rhesus macaque IP-10 shares 69 %, 95 %, 74 % a.a. sequence identity with human, mouse, rat IP-10. This chemokine elicits its effects by binding to the cell surface chemokine receptor CXCR3. CXCL10 has been shown to be a chemoattractant for activated Tlymphocytes. CXCL10 has been reported to be a potent inhibitor of angiogenesis and to display a potent thymus-dependent antitumor effect. CXCL10 is also recognized as a biomarker that predicts severity of various diseases.

Product Properties

Synonyms	Gamma-IP10, Small-inducible Cytokine B10, Protein Mob-1
Accession	P48973
GeneID	245920
Source	E.coli-derived rat IP-10/CXCL10 protein, Ile22-Pro98.
Molecular Weight	Approximately 8.7 kDa.
AA Sequence	IPLARTVRCT CIDFHEQPLR PRAIGKLEII PASLSCPHVE IIATMKKNNE KRCLNPESEA IKSLLKAVSQ RRSKRAP
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	>95% by SDS-PAGE and HPLC analyses.
Biological Activity	The biological activity determined by a chemotaxis bioassay using human CXCR3 transfected HEK293 cells is in a concentration range of 10-50 ng/ml. Fully biologically active when compared to standard.
Endotoxin	< 1.0 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20℃. Further dilutions should be made in appropriate buffered solutions.